Ranbaxy posts Rs.49 mn global operating loss

By IANS,

Gurgaon : India’s largest drug maker Ranbaxy Laboratories posted a global operating loss of Rs.49 million ($1.01 million) in the third quarter ended Sept 30, down 103 percent from an operating profit of Rs.1.62 billion ($36 million) that the company earned in the comparable period last year, top company officials said here Friday.

---

Support TwoCircles

---

The figure excludes foregn exchange losses and losses on translation and exceptional items.

The company’s global sales, however, grew 14.3 percent to Rs.18.88 billion ($420 million) up from Rs.16.52 billion ($367 million) that the company posted in the comparable period of last year, the company said.